Annual report pursuant to Section 13 and 15(d)

NON CONTROLLING INTEREST (Details)

v3.21.1
NON CONTROLLING INTEREST (Details) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net loss attributable to the non-controlling interest $ (34,276) $ (8,691)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss (141,638) (35,914)
Net loss attributable to the non-controlling interest $ (34,276) $ (8,691)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%